A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma

Clinical trial NCT04187404 · TERMINATED

Trial details

NCT number: NCT04187404
Sponsor: Enterome
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Adrenocortical Carcinoma Pheochromocytoma Paraganglioma

Start date: 2020-07-23
Primary completion: 2024-10-02
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.